While the inhibition of CXCL12 and CXCR4 can signifcantly reduce tumor cell proliferation and metastasis [34], indicating that CXCL12 is closely related to development, outcome and prognosis of colon cancers. Here, CXCR4 is linked to malignant colon neoplasm.